These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21988305)

  • 1. Laser vaccine adjuvant for cutaneous immunization.
    Chen X; Wu MX
    Expert Rev Vaccines; 2011 Oct; 10(10):1397-403. PubMed ID: 21988305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel laser vaccine adjuvant increases the motility of antigen presenting cells.
    Chen X; Kim P; Farinelli B; Doukas A; Yun SH; Gelfand JA; Anderson RR; Wu MX
    PLoS One; 2010 Oct; 5(10):e13776. PubMed ID: 21048884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot clinical trial of a near-infrared laser vaccine adjuvant: safety, tolerability, and cutaneous immune cell trafficking.
    Gelfand JA; Nazarian RM; Kashiwagi S; Brauns T; Martin B; Kimizuka Y; Korek S; Botvinick E; Elkins K; Thomas L; Locascio J; Parry B; Kelly KM; Poznansky MC
    FASEB J; 2019 Feb; 33(2):3074-3081. PubMed ID: 30192655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro-fractional epidermal powder delivery for improved skin vaccination.
    Chen X; Kositratna G; Zhou C; Manstein D; Wu MX
    J Control Release; 2014 Oct; 192():310-6. PubMed ID: 25135790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants.
    Chen X; Pravetoni M; Bhayana B; Pentel PR; Wu MX
    Vaccine; 2012 Dec; 31(1):159-64. PubMed ID: 23123021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging adjuvants for intradermal vaccination.
    Chen X
    Int J Pharm; 2023 Feb; 632():122559. PubMed ID: 36586639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
    Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser vaccine adjuvants. History, progress, and potential.
    Kashiwagi S; Brauns T; Gelfand J; Poznansky MC
    Hum Vaccin Immunother; 2014; 10(7):1892-907. PubMed ID: 25424797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass vaccination: solutions in the skin.
    Glenn GM; Kenney RT
    Curr Top Microbiol Immunol; 2006; 304():247-68. PubMed ID: 16989274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective and lesion-free cutaneous influenza vaccination.
    Wang J; Li B; Wu MX
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5005-10. PubMed ID: 25848020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing adjuvants for intradermal delivery of MenC glycoconjugate vaccine.
    Donadei A; Balocchi C; Romano MR; Panza L; Adamo R; Berti F; O'Hagan DT; Gallorini S; Baudner BC
    Vaccine; 2017 Jul; 35(32):3930-3937. PubMed ID: 28645718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the use of laser technology in skin vaccination.
    Chen X; Wang J; Shah D; Wu MX
    Expert Rev Vaccines; 2013 Nov; 12(11):1313-23. PubMed ID: 24127871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
    Wei J; Xue W; Yu X; Qiu X; Liu Z
    J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routing dependent immune responses after experimental R848-adjuvated vaccination.
    van Aalst S; Jansen MAA; Ludwig IS; van der Zee R; van Eden W; Broere F
    Vaccine; 2018 Mar; 36(11):1405-1413. PubMed ID: 29409680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvants in cutaneous vaccination: A comprehensive analysis.
    Oladejo M; Tijani AO; Puri A; Chablani L
    J Control Release; 2024 May; 369():475-492. PubMed ID: 38569943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapulmonary (i.pulmon.) Pull Immunization With the Tuberculosis Subunit Vaccine Candidate H56/CAF01 After Intramuscular (i.m.) Priming Elicits a Distinct Innate Myeloid Response and Activation of Antigen-Presenting Cells Than i.m. or i.pulmon. Prime Immunization Alone.
    Thakur A; Pinto FE; Hansen HS; Andersen P; Christensen D; Janfelt C; Foged C
    Front Immunol; 2020; 11():803. PubMed ID: 32457748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems.
    Puri N; Weyand EH; Abdel-Rahman SM; Sinko PJ
    Vaccine; 2000 May; 18(23):2600-12. PubMed ID: 10775794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Cutaneous Vaccine Adjuvant that STINGs a Little Less.
    Caucheteux SM; Piguet V
    J Invest Dermatol; 2016 Nov; 136(11):2127-2128. PubMed ID: 27772546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
    Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
    Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of cellular changes in mice after intradermal inoculation with a liposome-iscom adjuvanted vaccine.
    San Gil F; Turner B; Mullbacher A; Walker MJ; Djordjevic SP; Eamens GJ; Chin JC
    Scand J Immunol; 1998 Mar; 47(3):243-53. PubMed ID: 9519863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.